CVE-2025-0416
HIGH EPSS 7.0%
Published Apr 1, 20251y ago · Modified Jun 17, 20262w ago
8.9 CVSS 4.0
Published Apr 1, 2025 1y ago
Last Modified Jun 17, 2026 2w ago
Description
Local privilege escalation through insecure DCOM configuration in Valmet DNA versions prior to C2023. The DCOM object Valmet DNA Engineering has permissions that allow it to run commands as a user with the SeImpersonatePrivilege privilege. The SeImpersonatePrivilege privilege is a Windows permission that allows a process to impersonate another user. An attacker can use this vulnerability to escalate their privileges and take complete control of the system.
CVSS Details
Base Score
Exploitability
Impact
Vector string
CVSS:4.0/AV:A/AC:L/AT:P/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:N/AU:Y/R:U/V:D/RE:H/U:Amber Attack Vector Adjacent
Attack Complexity Low
Privileges Required Low
User Interaction None
Scope N
Threat Intelligence
EPSS Exploit Probability
7.0% percentile
Exploit & Patch Status
No Known Exploit
No Patch Available
Weaknesses 1
CWE-269 Improper Privilege Management Authorization
References 1
- valmet.com https://www.valmet.com/about-us/about/research-and-development/vulnerabilityadvisories/cve-2025-0416/
Remediation
No remediation data recorded yet
Check vendor advisories and the NVD entry for patch availability.